By Gina Shaw
Between Medicaid, state employee benefit plans, and the individual and small group commercial market, U.S. states have the authority to regulate prescription drug spending affecting about 119 million covered lives. But even with the historical tools that they have used to date, such as joint purchasing consortiums, supplemental rebate negotiations and preferred drug lists, they have struggled to deal with the cost of breakthrough therapies, said Melissa Andel, the principal of
OCTOBER 23, 2020